Chemoinformaics analysis of (6S,9R)-vomifoliol
| Molecular Weight | 224.3 | nRot | 2 |
| Heavy Atom Molecular Weight | 204.14 | nRig | 8 |
| Exact Molecular Weight | 224.141 | nRing | 1 |
| Solubility: LogS | -1.566 | nHRing | 0 |
| Solubility: LogP | 1.225 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 37.4519 |
| nHD | 2 | BPOL | 20.9321 |
| QED | 0.7 |
| Synth | 4.159 |
| Natural Product Likeliness | 3.112 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.019 |
| HIA | 0.009 |
| CACO-2 | -4.472 |
| MDCK | 0.0000257 |
| BBB | 0.932 |
| PPB | 0.684174 |
| VDSS | 1.232 |
| FU | 0.344669 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.463 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.874 |
| CYP2c9-inh | 0.033 |
| CYP2c9-sub | 0.334 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.358 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.607 |
| CL | 3.339 |
| T12 | 0.779 |
| hERG | 0.01 |
| Ames | 0.023 |
| ROA | 0.36 |
| SkinSen | 0.188 |
| Carcinogencity | 0.886 |
| EI | 0.096 |
| Respiratory | 0.348 |
| NR-Aromatase | 0.115 |
| Antiviral | Yes |
| Prediction | 0.768707 |